Investment and Project Progress - The total investment amount for the reporting period was ¥7,185,392,991.64, a decrease of 44.57% compared to ¥12,962,971,948.10 in the same period last year[1] - The annual production capacity for the new phosphate-based positive electrode material project is 110,000 tons, with an investment of ¥356,832,579.36 in the reporting period and a cumulative actual investment of ¥2,550,785,384.34, achieving 94.22% project progress[1] - The annual production capacity for the lithium iron phosphate project is 80,000 tons, with an investment of ¥680,662,395.62 in the reporting period and a cumulative actual investment of ¥1,804,482,587.66, achieving 90.08% project progress[1] - The annual production capacity for the lithium supplement project is 20,000 tons, with an investment of ¥99,940,892.91 in the reporting period and a cumulative actual investment of ¥637,192,633.10, achieving 85.34% project progress[1] - The total amount of committed investment projects is CNY 316,125.65 million, with a cumulative investment of CNY 291,161.29 million, achieving an investment progress of 88.98%[20] - The project for producing 110,000 tons of new phosphate-based cathode materials has a total investment of CNY 230,000 million, with CNY 204,643.63 million invested to date[20] - The company is currently in the construction phase for all major projects, indicating ongoing expansion efforts in the lithium-ion battery materials sector[1] - The company plans to continue its investment strategy focusing on the lithium-ion battery materials manufacturing industry, aiming for increased production capacity and market share[1] Financial Performance - The company's operating revenue for 2023 was CNY 1,697,250.89 million, a decrease of 24.76% compared to 2022[43] - The total operating revenue for 2023 was ¥16,972,508,924.23, a decrease of approximately 24.5% compared to ¥22,557,078,113.42 in 2022[113] - The company reported a net loss of ¥1,981,729,580.82 for 2023, compared to a net profit of ¥2,407,404,727.27 in 2022[117] - The total comprehensive income attributable to the parent company for 2023 was -2,112,836,943.84, compared to 2,151,715,009.12 in 2022, indicating a significant decline[119] - The basic earnings per share for 2023 was -5.87, down from 8.91 in 2022, reflecting a substantial loss[119] - The total profit for 2023 was -148,213,369.27, down from 319,764,633.77 in 2022, reflecting a significant loss[122] Cash Flow and Liquidity - The net cash flow from operating activities for 2023 was 5,993,449,336.77, a recovery from a negative cash flow of -6,135,947,711.77 in 2022[124] - The net cash flow from financing activities for 2023 was -2,888,899,854.49, a decrease from a positive cash flow of 10,741,069,962.75 in 2022[125] - The company's current assets decreased to CNY 9,202,058,604.51 from CNY 18,307,270,456.06, indicating a significant reduction in liquidity[99] - Cash and cash equivalents were reported at CNY 2,863,753,185.05, down from CNY 3,513,218,178.72, reflecting a decline of approximately 18.5%[99] - The company’s cash and cash equivalents decreased significantly, with current assets totaling ¥1,527,349,637.12 compared to ¥4,064,128,495.92 at the beginning of the year[112] - The company reported an asset impairment loss of ¥1.04 billion, accounting for 47.69% of total profit, primarily due to inventory write-downs[184] Research and Development - Research and development expenses increased to ¥552,341,508.31 in 2023, up from ¥432,362,468.12 in 2022, representing a growth of approximately 27.8%[117] - The company plans to enhance R&D capabilities, focusing on new phosphate-based cathode materials and high-performance auxiliary materials to improve energy density and reduce costs[60] - The company is focusing on the research of lithium-ion battery cathode lithium supplementation technology to enhance battery performance, currently in the R&D phase[177] - The development of a new high-performance lithium iron phosphate material aims to enhance energy density and compaction density, currently in the small trial stage[177] - The project on high-efficiency sintering technology for lithium iron phosphate aims to increase production capacity while reducing manufacturing costs[177] Risk Management and Compliance - The company has implemented a risk control system for its hedging operations, including monitoring market conditions and adjusting strategies accordingly[10] - The company emphasizes the importance of internal control and compliance with relevant laws and regulations in its hedging activities[13] - The company has established a comprehensive internal control system to manage risks and ensure the normal operation of business activities[141] - The company is committed to enhancing its corporate governance structure in compliance with relevant laws and regulations[85] Market Strategy and Future Plans - The company aims to become a global leader in new energy material solutions, focusing on phosphate-based cathode materials as the core of its business strategy[58] - The company plans to continue expanding its market presence and developing new technologies[78] - The company aims to mitigate risks associated with the volatility of lithium salt product prices through its hedging activities[13] - The company is closely monitoring industry policy changes to adapt its strategies and maintain competitiveness in the evolving new energy vehicle market[73] Shareholder and Governance - The company has no controlling shareholders or actual controllers, maintaining independence in its operations and governance[143] - The company’s board of directors convened shareholder meetings to ensure shareholders' rights to information and participation were upheld[86] - The company has implemented a long-term incentive mechanism through stock option plans, enhancing employee motivation and aligning interests with shareholders[140] - The company has established a management system for hedging operations, detailing approval authority, organizational structure, and risk management measures[10]

Financial Performance - The company's operating revenue for Q1 2024 was ¥1,892,057,814.82, a decrease of 61.74% compared to ¥4,944,745,935.53 in the same period last year[3] - The net profit attributable to shareholders for Q1 2024 was -¥184,679,966.25, representing an improvement of 74.25% from -¥717,334,775.51 in the previous year[3] - The basic earnings per share for Q1 2024 was -¥0.66, a 74.52% improvement from -¥4.14 in the same period last year[3] - The company reported a net loss of ¥212,614,747.44 for the current period, an improvement from a net loss of ¥907,989,332.91 in the previous period[41] - The total comprehensive loss attributable to the parent company was ¥184,679,966.25, compared to a loss of ¥717,334,775.51 in the previous period[41] - The total comprehensive income for the period attributable to the parent company was -259,198,304.54 CNY, compared to -761,021,237.74 CNY in the previous period, indicating an improvement of approximately 65.98%[61] - Basic and diluted earnings per share for the current period were both -0.66 CNY, compared to -2.59 CNY and -2.56 CNY respectively in the previous period, reflecting a significant reduction in losses[61] Cash Flow - The net cash flow from operating activities was -¥717,743,066.60, which is an 8.38% improvement compared to -¥783,419,218.59 in the same period last year[3] - The net cash flow from investing activities was ¥754,614,121.82, a significant increase of 203.24% from -¥730,915,260.27 in the previous period[27] - Cash inflows from operating activities totaled 622,125,677.41 CNY, down 72.0% from 2,223,297,357.62 CNY in the previous period[61] - The net increase in cash and cash equivalents for the period was -372,406,932.20 CNY, compared to -228,366,584.04 CNY in the previous period, indicating a worsening cash flow situation[64] - The company reported cash received from sales and services of 523,591,786.33 CNY, a decrease of 75.0% from 2,102,585,131.06 CNY in the previous period[61] - Other cash received related to operating activities amounted to 98,533,891.08 CNY, down from 120,712,226.56 CNY in the previous period, a decline of approximately 18.4%[61] Assets and Liabilities - Total assets amounted to ¥19,381,235,660.42, reflecting a decrease of 6.53% from ¥20,734,958,524.59[23] - The equity attributable to shareholders of the listed company was ¥6,854,050,089.20, down 3.79% from ¥7,123,957,269.37[23] - Total liabilities decreased to CNY 10,960,892,567.57 from CNY 12,018,332,973.96, indicating a decline of approximately 8.8%[56] - Cash and cash equivalents decreased to CNY 2,371,061,691.91 from CNY 2,863,753,185.05, a decline of approximately 17.1%[54] - Accounts receivable dropped to CNY 1,689,653,014.13 from CNY 2,282,846,247.42, reflecting a decrease of about 26.0%[54] Operational Costs - The company's operating costs for Q1 2024 were ¥1,891,500,880.18, also down by 61.74% from ¥4,944,378,687.64 in the previous year[9] - The financial expenses decreased by 48.78% to ¥39,265,174.05 from ¥76,659,309.72 in the same period last year[9] - The company reported a significant reduction in asset impairment losses, which decreased by 95.44% to -¥36,988,920.91 from -¥810,881,951.67 in the previous year[9] - Total operating costs amounted to CNY 2,150,116,187.85, down from CNY 5,295,603,524.53, indicating a reduction of about 59.4%[58] Shareholder Information - The total number of common shareholders at the end of the reporting period was 38,715[48] - The largest shareholder, Ji Xuewen, holds 13.93% of shares, amounting to 38,897,664 shares[48] - The second-largest shareholder, Kong Lingyong, holds 13.02% of shares, amounting to 36,346,579 shares[48] Future Plans and Changes - The company plans to repurchase shares with a total amount not less than ¥100 million and not exceeding ¥200 million, with a maximum repurchase price of ¥112.69 per share[32] - The company has implemented new accounting standards starting from 2024, affecting the financial statements[47]

审计报告 深圳市德方纳米科技股份有限公司 容诚审字[2024]518Z0006 号 容诚会计师事务所(特殊普通合伙) 中国·北京 目 录 | 序号 | 内 容 | 页码 | | | --- | --- | --- | --- | | 1 | 审计报告 | 1 - | 7 | | 2 | 合并资产负债表 | 8 | | | 3 | 合并利润表 | 9 | | | 4 | 合并现金流量表 | 10 | | | 5 | 合并所有者权益变动表 | 11 - | 12 | | 6 | 母公司资产负债表 | 13 | | | 7 | 母公司利润表 | 14 | | | 8 | 母公司现金流量表 | 15 | | | 9 | 母公司所有者权益变动表 | 16 - | 17 | | 10 | 财务报表附注 | 18 - | 154 | 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 外经贸大厦 15 层 / 922-926 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.g ...

证券代码：300769 证券简称：德方纳米 公告编号：2024-039 …… 7、出席对象： （1）在股权登记日持有公司股份的股东或代理人； 截至2024年5月16日下午收市时在中国证券登记结算有限责任公司深圳分公 司登记在册的公司全体已发行有表决权股份的股东均有权出席本次股东大会，并 可以以书面形式委托代理人出席会议和参加表决（授权委托书见附件二），该股 东代理人不必是本公司股东。 更正后： 深圳市德方纳米科技股份有限公司 关于召开 2023 年年度股东大会通知的更正公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 深圳市德方纳米科技股份有限公司（以下简称"公司"、"德方纳米"）于 2024年4月24日在巨潮资讯网（www.cninfo.com.cn）上披露了《关于召开公司2023 年年度股东大会的通知》（公告编号：2024-036）。经检查发现，原公告部分内 容有误，现更正如下： 更正前： 一、 召开会议的基本情况 一、 召开会议的基本情况 …… 7、出席对象： （1）在股权登记日持有公司股份的股东或代理人； 1 截至2024年5月9日下午收市时在中国 ...

证券代码：300769 证券简称：德方纳米 公告编号：2024-040 深圳市德方纳米科技股份有限公司 关于全资子公司为公司提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 担保情况概述 为满足生产经营及业务拓展的资金需求，深圳市德方纳米科技股份有限公司 （以下简称"公司"）向中国银行股份有限公司深圳高新区支行（以下简称"中 国银行深圳高新区支行"）申请总额为人民币2,300.00万元整的流动资金借款， 并签署《流动资金借款合同》，公司的全资子公司曲靖市德方纳米科技有限公司 （以下简称"曲靖德方"）为公司的上述流动资金借款额度提供连带责任担保， 担保总额度为人民币2,300.00万元整。 | 主要财务数据 | 2022 年 | 12 月 | 31 | 日（经审计） | 2023 年 | 12 | 月 31 | 日（经审计） | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 资产总额 | | | | 2,909,424.43 | | | | 2,073,495.85 | | ...

证券研究报告 2024 年 04 月 25 日 公 司 报 告│ 公 司 年 报 点 评 德方纳米(300769) 出货量稳步增长，补锂剂有望贡献新业绩增长点 事件： 公司发布 2023 年年度报告，2023 年实现营收 169.73 亿元，同比-24.76%， 归母净利润-16.36 亿元，同比-168.74%。23Q4 实现营收 26.66 亿元，同比 -67.26%，环比-50.76%，归母净利润-6.40 亿元，同比-215.85%，环比1441.05%。 出货量稳步增长，价格及资产减值影响净利 23 年碳酸锂价格剧烈波动，虽然公司磷酸盐系正极材料出货量同比增长， 但难抵销售价格下降与资产减值导致净利下降。23 年公司磷酸盐系正极材 料产量 20.52 万吨，同比+10.62%，销量 21.39 万吨，同比+24.15%。目前 公司依据订单计划和碳酸锂价格波动情况动态灵活调整存货，缩短原材料 库存周期，实现公司稳定发展。23 年公司继续加大研发投入，研发费用为 5.52 亿元，同比+27.75%。 前瞻布局磷酸锰铁锂，新产品新技术加速落地 截至 24 年 3 月，公司磷酸铁锂产能达 26.5 万吨/年 ...

Investment Rating - The investment rating for the company is "Buy" [3][15]. Core Views - The company is expected to recover from losses in 2024, with a projected net profit of 1.8 billion yuan, and further growth anticipated in subsequent years, reaching 9 billion yuan by 2026 [15]. - The company has faced challenges due to a decline in sales and profitability in 2023, with a significant drop in revenue and net profit compared to the previous year [3][14]. - Despite the current downturn, the company is positioned as a leader in the lithium iron phosphate market, maintaining a competitive edge in the long term [15]. Financial Performance Summary - In 2023, the company reported total revenue of 16.973 billion yuan, a decrease of 24.76% year-on-year, and a net loss of 1.636 billion yuan, down 168.74% year-on-year [3][15]. - The gross margin for 2023 was 0.2%, reflecting a decline of 20 percentage points compared to the previous year, while the net margin was -12%, down 22 percentage points year-on-year [3]. - The company’s earnings per share (EPS) for 2023 was -5.86 yuan, with a projected EPS of 0.64 yuan in 2024 and 3.35 yuan in 2026 [15][20]. Production and Sales Outlook - The company’s production capacity is expected to reach 45,000 tons by mid-2024, with a forecasted sales volume of approximately 300,000 tons in 2024, representing a 38% increase year-on-year [2][3]. - The company has a high customer concentration, primarily serving leading firms such as CATL and BYD, with a significant portion of sales coming from energy storage applications [2][3]. Cash Flow and Asset Management - The company reported a significant increase in operating cash flow in 2023, amounting to 6 billion yuan, which is a 198% increase year-on-year [4]. - The total assets of the company are projected to grow from 20.735 billion yuan in 2023 to 29.301 billion yuan by 2026 [8][20].

证券代码：300769 证券简称：德方纳米 公告编号：2024-027 深圳市德方纳米科技股份有限公司 关于第二期限制性股票激励计划首次授予第三个归属期及预留授予第二个归属 期归属条件成就的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 首次授予第三个归属期限制性股票可归属数量：1,294,501股 预留授予第二个归属期限制性股票可归属数量：158,400股 股票来源：公司定向增发A股普通股 一、股权激励计划实施情况概要 （一）股权激励计划简介 公司分别于2021年1月18日、2021年2月4日召开第三届董事会第九次会议、 2021年第一次临时股东大会，审议通过第二期限制性股票激励计划（以下简称"本 激励计划"），主要内容如下： 1、股权激励方式：第二类限制性股票。 2、授予数量：本激励计划拟授予限制性股票135.00万股，占本激励计划草 案公告时公司股本总额的1.50%。其中，首次授予121.50万股，占本激励计划草 案公告时公司股本总额的1.35%，占拟授予权益总额的90.00%；预留授予13.50 万股，占本激励计划草案公告时公司股 ...

北京市中伦（深圳）律师事务所 关于深圳市德方纳米科技股份有限公司 第二期限制性股票激励计划授予价格及授予数量调整、 首次授予第三个归属期及预留授予第二个归属期归属条件成就、 作废部分限制性股票相关事项的 法律意见书 二〇二四年四月 法律意见书 （1）文件上所有的签名、印鉴都是真实的； - 2 - 北京市中伦（深圳）律师事务所 关于深圳市德方纳米科技股份有限公司 第二期限制性股票激励计划授予价格及授予数量调整、 首次授予第三个归属期及预留授予第二个归属期归属条件成就、 作废部分限制性股票相关事项的 法律意见书 致：深圳市德方纳米科技股份有限公司 北京市中伦（深圳）律师事务所（以下简称"本所"）作为深圳市德方纳米 科技股份有限公司（以下简称"公司"或"德方纳米"）聘请的专项法律顾问， 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券 法》（以下简称"《证券法》"）、《深圳证券交易所创业板股票上市规则（2023 年 8 月修订）》（以下简称"《上市规则》"）以及中国证券监督管理委员会（以下简称 "中国证监会"）发布的《上市公司股权激励管理办法》（以下简称"《管理办法》"） 等有关法律、法 ...

北京市中伦（深圳）律师事务所 关于深圳市德方纳米科技股份有限公司 第四期限制性股票激励计划作废部分限制性股票的 法律意见书 二〇二四年四月 法律意见书 北京市中伦（深圳）律师事务所 关于深圳市德方纳米科技股份有限公司 第四期限制性股票激励计划作废部分限制性股票的 法律意见书 致：深圳市德方纳米科技股份有限公司 - 2 - 法律意见书 （4）该等文件中所陈述的事实均真实、准确、完整，并没有遗漏和/或误导。 为出具本法律意见书，本所律师特作如下声明： （1）本法律意见书系依据本法律意见书出具日以前已经发生或存在的事实， 根据适用的中国法律、法规和规范性文件而出具。 北京市中伦（深圳）律师事务所（以下简称"本所"）作为深圳市德方纳米 科技股份有限公司（以下简称"公司"或"德方纳米"）聘请的专项法律顾问， 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券 法》（以下简称"《证券法》"）、《深圳证券交易所创业板股票上市规则（2023 年 8 月修订）》（以下简称"《上市规则》"）以及中国证券监督管理委员会（以下简称 "中国证监会"）发布的《上市公司股权激励管理办法》（以下简称"《管理办法》" ...